AngioDynamics Historical Balance Sheet

ANGO Stock

USD 10.08 0.16 1.61%

Trend analysis of AngioDynamics balance sheet accounts such as Total Assets of 525.4 M, Short and Long Term Debt Total of 6.5 M or Other Current Liab of 61.5 M provides information on AngioDynamics' total assets, liabilities, and equity, which is the actual value of AngioDynamics to its prevalent stockholders. By breaking down trends over time using AngioDynamics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining AngioDynamics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether AngioDynamics is a good buy for the upcoming year.

AngioDynamics Inventory

43.57 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

About AngioDynamics Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of AngioDynamics at a specified time, usually calculated after every quarter, six months, or one year. AngioDynamics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of AngioDynamics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which AngioDynamics currently owns. An asset can also be divided into two categories, current and non-current.

AngioDynamics Balance Sheet Chart

At this time, AngioDynamics' Long Term Debt is very stable compared to the past year. As of the 24th of March 2025, Liabilities And Stockholders Equity is likely to grow to about 525.4 M, while Common Stock Shares Outstanding is likely to drop about 30 M.

Common Stock Shares Outstanding Total Assets Short Long Term Debt Total Other Current Liab Accounts Payable

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of AngioDynamics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in AngioDynamics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Accounts Payable

An accounting item on the balance sheet that represents AngioDynamics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of AngioDynamics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from AngioDynamics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into AngioDynamics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.At this time, AngioDynamics' Long Term Debt is very stable compared to the past year. As of the 24th of March 2025, Liabilities And Stockholders Equity is likely to grow to about 525.4 M, while Common Stock Shares Outstanding is likely to drop about 30 M.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	64.6M	5.9M	6.8M	6.5M
Total Assets	532.6M	317.7M	365.3M	525.4M

Short Long Term Debt Total Total Assets

AngioDynamics balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets
Common Stock Shares Outstanding		0.4	-0.01	0.42	0.69	0.41	0.48	0.02	-0.23	-0.34	0.5	0.38	0.28	0.2	0.06	0.34	0.64	0.95	-0.35	0.09	0.8	0.16	0.96	0.35	0.42	0.68
Total Assets	0.4		0.82	-0.21	0.19	0.99	0.63	0.46	0.48	0.57	0.03	0.21	0.93	-0.05	0.78	0.22	0.68	0.55	0.2	0.86	0.49	-0.11	0.47	0.92	-0.11	0.48
Short Long Term Debt Total	-0.01	0.82		-0.49	-0.17	0.75	0.56	0.4	0.76	0.81	-0.22	0.01	0.88	-0.16	0.92	0.01	0.54	0.14	0.4	0.97	0.24	-0.21	0.07	0.89	-0.36	0.2
Other Current Liab	0.42	-0.21	-0.49		0.8	-0.21	0.07	-0.66	-0.61	-0.78	0.82	0.33	-0.47	0.22	-0.28	0.35	0.25	0.38	-0.2	-0.49	0.21	0.59	0.44	-0.19	0.75	0.45
Total Current Liabilities	0.69	0.19	-0.17	0.8		0.18	0.43	-0.44	-0.34	-0.65	0.9	0.31	-0.1	0.38	0.08	0.33	0.6	0.69	-0.17	-0.15	0.6	0.61	0.72	0.21	0.83	0.62
Total Stockholder Equity	0.41	0.99	0.75	-0.21	0.18		0.56	0.53	0.4	0.55	0.0	0.24	0.9	-0.02	0.69	0.25	0.62	0.55	0.19	0.79	0.45	-0.12	0.48	0.84	-0.14	0.48
Property Plant And Equipment Net	0.48	0.63	0.56	0.07	0.43	0.56		-0.17	0.63	0.11	0.43	-0.29	0.64	0.18	0.63	-0.28	0.88	0.61	0.31	0.61	0.78	0.36	0.57	0.76	0.39	0.2
Current Deferred Revenue	0.02	0.46	0.4	-0.66	-0.44	0.53	-0.17		0.13	0.67	-0.66	0.29	0.53	-0.19	0.21	0.27	-0.11	0.04	-0.04	0.41	-0.11	-0.5	-0.02	0.24	-0.58	0.14
Net Debt	-0.23	0.48	0.76	-0.61	-0.34	0.4	0.63	0.13		0.66	-0.27	-0.63	0.69	-0.18	0.64	-0.63	0.4	-0.09	0.48	0.76	0.22	-0.08	-0.16	0.62	-0.25	-0.4
Retained Earnings	-0.34	0.57	0.81	-0.78	-0.65	0.55	0.11	0.67	0.66		-0.69	-0.04	0.74	-0.34	0.6	-0.04	0.03	-0.24	0.3	0.79	-0.21	-0.53	-0.32	0.54	-0.74	-0.11
Accounts Payable	0.5	0.03	-0.22	0.82	0.9	0.0	0.43	-0.66	-0.27	-0.69		0.12	-0.22	0.41	0.04	0.15	0.55	0.53	0.01	-0.22	0.55	0.74	0.57	0.11	0.82	0.45
Cash	0.38	0.21	0.01	0.33	0.31	0.24	-0.29	0.29	-0.63	-0.04	0.12		-0.02	0.07	0.11	1.0	0.01	0.34	-0.26	-0.02	-0.01	-0.12	0.35	0.1	-0.04	0.86
Non Current Assets Total	0.28	0.93	0.88	-0.47	-0.1	0.9	0.64	0.53	0.69	0.74	-0.22	-0.02		-0.17	0.74	-0.03	0.6	0.41	0.27	0.93	0.43	-0.27	0.33	0.88	-0.33	0.22
Other Assets	0.2	-0.05	-0.16	0.22	0.38	-0.02	0.18	-0.19	-0.18	-0.34	0.41	0.07	-0.17		0.03	0.1	0.13	0.24	0.13	-0.24	0.2	0.34	0.25	-0.1	0.4	0.18
Long Term Debt	0.06	0.78	0.92	-0.28	0.08	0.69	0.63	0.21	0.64	0.6	0.04	0.11	0.74	0.03		0.13	0.6	0.23	0.45	0.88	0.36	0.04	0.16	0.9	-0.07	0.36
Cash And Short Term Investments	0.34	0.22	0.01	0.35	0.33	0.25	-0.28	0.27	-0.63	-0.04	0.15	1.0	-0.03	0.1	0.13		0.02	0.33	-0.21	-0.02	-0.02	-0.08	0.34	0.1	-0.01	0.87
Net Receivables	0.64	0.68	0.54	0.25	0.6	0.62	0.88	-0.11	0.4	0.03	0.55	0.01	0.6	0.13	0.6	0.02		0.75	0.17	0.54	0.81	0.43	0.72	0.76	0.41	0.49
Common Stock Total Equity	0.95	0.55	0.14	0.38	0.69	0.55	0.61	0.04	-0.09	-0.24	0.53	0.34	0.41	0.24	0.23	0.33	0.75		-0.05	0.22	0.87	0.27	1.0	0.47	0.42	0.71
Short Term Investments	-0.35	0.2	0.4	-0.2	-0.17	0.19	0.31	-0.04	0.48	0.3	0.01	-0.26	0.27	0.13	0.45	-0.21	0.17	-0.05		0.28	0.09	0.3	-0.08	0.22	-0.07	-0.1
Non Current Liabilities Total	0.09	0.86	0.97	-0.49	-0.15	0.79	0.61	0.41	0.76	0.79	-0.22	-0.02	0.93	-0.24	0.88	-0.02	0.54	0.22	0.28		0.32	-0.28	0.14	0.93	-0.34	0.19
Inventory	0.8	0.49	0.24	0.21	0.6	0.45	0.78	-0.11	0.22	-0.21	0.55	-0.01	0.43	0.2	0.36	-0.02	0.81	0.87	0.09	0.32		0.4	0.86	0.54	0.47	0.46
Other Current Assets	0.16	-0.11	-0.21	0.59	0.61	-0.12	0.36	-0.5	-0.08	-0.53	0.74	-0.12	-0.27	0.34	0.04	-0.08	0.43	0.27	0.3	-0.28	0.4		0.3	-0.05	0.83	0.18
Other Stockholder Equity	0.96	0.47	0.07	0.44	0.72	0.48	0.57	-0.02	-0.16	-0.32	0.57	0.35	0.33	0.25	0.16	0.34	0.72	1.0	-0.08	0.14	0.86	0.3		0.41	0.45	0.71
Total Liab	0.35	0.92	0.89	-0.19	0.21	0.84	0.76	0.24	0.62	0.54	0.11	0.1	0.88	-0.1	0.9	0.1	0.76	0.47	0.22	0.93	0.54	-0.05	0.41		-0.03	0.42
Property Plant And Equipment Gross	0.42	-0.11	-0.36	0.75	0.83	-0.14	0.39	-0.58	-0.25	-0.74	0.82	-0.04	-0.33	0.4	-0.07	-0.01	0.41	0.42	-0.07	-0.34	0.47	0.83	0.45	-0.03		0.25
Total Current Assets	0.68	0.48	0.2	0.45	0.62	0.48	0.2	0.14	-0.4	-0.11	0.45	0.86	0.22	0.18	0.36	0.87	0.49	0.71	-0.1	0.19	0.46	0.18	0.71	0.42	0.25

Click cells to compare fundamentals

AngioDynamics Account Relationship Matchups

AngioDynamics balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	38.3M	39.0M	39.5M	40.2M	46.2M	30.0M
Total Assets	561.4M	552.8M	532.6M	317.7M	365.3M	525.4M
Short Long Term Debt Total	22.4M	33.8M	64.6M	5.9M	6.8M	6.5M
Other Current Liab	38.0M	43.0M	43.4M	50.9M	58.5M	61.5M
Total Current Liabilities	57.6M	74.3M	83.8M	91.2M	104.8M	110.1M
Total Stockholder Equity	439.5M	424.5M	378.3M	205.6M	236.4M	396.5M
Property Plant And Equipment Net	37.1M	45.0M	44.4M	41.5M	47.7M	35.4M
Net Debt	(28.2M)	5.0M	5.2M	(71.3M)	(64.2M)	(61.0M)
Retained Earnings	(131.9M)	(158.4M)	(210.9M)	(395.2M)	(355.7M)	(337.9M)
Accounts Payable	19.6M	28.0M	40.4M	37.8M	43.4M	45.6M
Cash	48.2M	28.8M	44.6M	76.1M	87.5M	47.3M
Non Current Assets Total	420.6M	409.4M	369.1M	124.4M	143.1M	135.9M
Other Assets	5.2M	3.8M	11.0M	49.2M	56.6M	59.4M
Long Term Debt	40M	20M	25M	49.8M	57.3M	58.7M
Cash And Short Term Investments	48.2M	28.8M	44.6M	76.1M	87.5M	62.7M
Net Receivables	35.4M	52.3M	52.8M	43.6M	50.2M	38.7M
Common Stock Total Equity	374K	377K	380K	382K	439.3K	308.9K
Liabilities And Stockholders Equity	561.4M	552.8M	532.6M	317.7M	365.3M	525.4M
Non Current Liabilities Total	64.4M	53.9M	70.5M	20.9M	24.1M	22.9M
Inventory	48.6M	51.4M	55.3M	60.6M	69.7M	43.6M
Other Current Assets	1.8M	14.5M	4.6M	13.0M	14.9M	15.7M
Other Stockholder Equity	567.8M	581.2M	593.5M	604.8M	695.5M	434.9M
Total Liab	122.0M	128.3M	154.3M	112.1M	128.9M	128.9M
Property Plant And Equipment Gross	37.1M	96.1M	44.4M	108.7M	125.0M	131.3M
Total Current Assets	140.9M	143.3M	163.5M	193.3M	222.2M	153.9M
Accumulated Other Comprehensive Income	3.2M	1.4M	(4.7M)	(4.4M)	(3.9M)	(3.7M)
Short Term Debt	2.4M	2.6M	14.8M	2.0M	2.3M	2.2M
Intangible Assets	169.0M	152.4M	111.1M	77.4M	89.0M	112.1M
Common Stock	377K	380K	382K	385K	442.8K	314.6K
Property Plant Equipment	28.3M	37.1M	45.0M	44.4M	51.0M	34.9M
Non Currrent Assets Other	13.2M	(5.1M)	54.3M	5.6M	6.4M	7.4M
Other Liab	39.6M	37.1M	24.2M	17.4M	20.0M	32.6M
Good Will	347.7M	201.5M	201.3M	201.1M	159.2M	0.0
Net Tangible Assets	57.2M	69.2M	71.1M	378.3M	435.0M	456.8M
Retained Earnings Total Equity	(100.3M)	(131.9M)	(158.4M)	(210.9M)	(189.8M)	(180.3M)
Long Term Debt Total	40M	20M	25M	49.8M	44.8M	69.2M
Capital Surpluse	561.9M	573.5M	586.9M	599.2M	689.1M	600.4M
Deferred Long Term Liab	24.1M	20.0M	16.0M	12.8M	14.7M	14.1M

When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:

How To Invest In AngioDynamics

Details

Is AngioDynamics Stock a good investment?

Details

What is AngioDynamics' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(5.59)

Revenue Per Share

7.064

Quarterly Revenue Growth

(0.08)

Return On Assets

(0.06)

Return On Equity

(0.76)

The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

AngioDynamics Historical Balance Sheet

AngioDynamics Inventory

43.57 Million

About AngioDynamics Balance Sheet Analysis

AngioDynamics Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Accounts Payable

AngioDynamics balance sheet Correlations

AngioDynamics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

AngioDynamics balance sheet Accounts

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Other Stockholder Equity	+ 1.0	Common Stock Total Equity
Total Stockholder Equity	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.97	Short Long Term Debt Total
Other Stockholder Equity	+ 0.96	Common Stock Shares Outstanding
Common Stock Total Equity	+ 0.95	Common Stock Shares Outstanding

Retained Earnings	- 0.78	Other Current Liab
Property Plant And Equipment Gross	- 0.74	Retained Earnings
Accounts Payable	- 0.69	Retained Earnings
Accounts Payable	- 0.66	Current Deferred Revenue
Current Deferred Revenue	- 0.66	Other Current Liab
Retained Earnings	- 0.65	Total Current Liabilities